Search

everythinglearnresearchcommunity

for

Search:↓

The issue covers reproductive health topics like cancer markers, incontinence treatments, and the impact of pre-term birth.

Cyclosporine A may help treat hair loss by blocking a protein that inhibits hair growth.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

A patient's skin eruption was caused by the cancer drug cyclophosphamide and improved after stopping the drug.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

Dermatologists greatly affect inpatient diagnosis and treatment of skin conditions, especially in spotting infections in patients with weakened immune systems.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

Lavender oil use in a child may be linked to early puberty signs and elevated tumor marker levels.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

A man treated with gefitinib for lung cancer grew new hair on his bald scalp.

The man had a fungal infection in his knee, treated with surgery and antifungal medication.

RAPK is a rare skin disorder with pigmented spots, mainly on hands and feet, starting in youth.

Chemotherapy provides symptom relief and extends life in 30-50% of gynecological cancer cases, but has only cured choriocarcinoma.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Finasteride improves prostate cancer detection in PSA test.

Wearing a frozen glove during chemotherapy can reduce nail and skin problems but may not be comfortable for everyone.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Rind-based techniques can lower scalp radiation dose and reduce hair loss in brain cancer treatment.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Keratin 18 helps diagnose and predict cancer progression and affects cancer growth and spread.

Endocrine therapies for cancer significantly increase the risk of hair loss.